Fingerprint
Dive into the research topics of 'Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically